{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:45:15Z","timestamp":1793943915187,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100031135","name":"Stiftelsen H\u00e4stforskning","doi-asserted-by":"publisher","award":["H-24-47-836"],"award-info":[{"award-number":["H-24-47-836"]}],"id":[{"id":"10.13039\/100031135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["Network for One Health Resistome Surveillance (NORSE): 299159"],"award-info":[{"award-number":["Network for One Health Resistome Surveillance (NORSE): 299159"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antibacterials are essential for treating infections in horses, but the use contributes to antimicrobial resistance (AMR), which threatens animal and human health. Despite these concerns, antibacterial use in horses has not been systematically studied and described in Norway, and nationwide registry-based analyses in other countries are scarce. The aim of this study is to describe antibacterial use in Norwegian horses, 2022\u20132024, by analysing nationwide registry data, with a particular emphasis on gynecological and obstetrical conditions. In addition, we will evaluate the data quality in light of the upcoming EU reporting requirements for data on antibacterial use in horses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 30,362 records reported to the Norwegian Veterinary Prescription Registry (VetReg) were included. Of these, 42.5% were reported by veterinarians and 57.5% by pharmacies. The two most common diagnostic groups treated were skin and hoof conditions and musculoskeletal conditions, accounting for approximately half of all records. Gynecological and obstetrical conditions accounted for 4% of the records.<\/jats:p>\n                    <jats:p>Antibacterial use (in kg active substance) was dominated by oral paste containing the combination of sulphonamide and trimethoprim (&gt;\u200990% in all three years), followed by injections with beta-lactamase sensitive penicillins. AMEG category D antibacterials (prudent use) accounted for\u2009&gt;\u200999% of the use. These patterns were also observed for gynecological and obstetrical conditions.<\/jats:p>\n                    <jats:p>The completeness of data on antibacterial use in horses in VetReg, in relation to sales data, increased from 75.5% in 2022 to 84.7% in 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      A higher proportion of AMEG category D antibacterials (&gt;\u200999%) was observed in our study than in Spain (85%). However, increasing carriage of resistant\n                      <jats:italic>E. coli<\/jats:italic>\n                      in the general horse population suggests that the extensive use of sulphonamide\u2009+\u2009trimethoprim should be further evaluated. Prudent use could be evaluated to some extent, but the reporting of general organ-related diagnostic codes limited this evaluation. Lack of fully reliable population data for horses limits how differences in antibiotic use between years and countries can be described and evaluated. VetReg data quality for horses was in line with or better than for the species for which data are already reported to the European Medicines Agency.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12917-026-05474-z","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:06:39Z","timestamp":1776323199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antibacterial use in Norwegian horses: a nationwide registry-based cross-sectional study"],"prefix":"10.1186","volume":"22","author":[{"given":"Leif Lukas","family":"L\u00f6fling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S.","family":"Haadem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvid","family":"Reiersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"B\u00f6rjesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari Olli","family":"Helgesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"2","key":"5474_CR1","first-page":"e8589","volume":"22","author":"European Centre for Disease Prevention Control","year":"2024","unstructured":"European Centre for Disease Prevention Control, European Food Safety Authority, European Medicines Agency. Antimicrobial consumption and resistance in bacteria from humans and food-producing animals. EFSA J. 2024;22(2):e8589.","journal-title":"EFSA J"},{"key":"5474_CR2","doi-asserted-by":"publisher","first-page":"100593","DOI":"10.1016\/j.onehlt.2023.100593","volume":"17","author":"M Jin","year":"2023","unstructured":"Jin M, Osman M, Green BA, Yang Y, Ahuja A, Lu Z, et al. Evidence for the transmission of antimicrobial resistant bacteria between humans and companion animals: a scoping review. One Health. 2023;17:100593.","journal-title":"One Health"},{"key":"5474_CR3","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Ventas y Uso de Antimicrobianos para Medicina Veterinaria en Espa\u00f1a 2023. https:\/\/resistenciaantibioticos.es\/sites\/default\/files\/2025-03\/Informe%20Espa%C3%B1ol%20ESUAvet%202023.pdf. Accessed 2025\u201311\u201318."},{"key":"5474_CR4","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Consumos Antibi\u00f3ticos en Veterinaria. https:\/\/www.resistenciaantibioticos.es\/es\/lineas-de-accion\/vigilancia\/mapas-de-consumo\/consumos-antibioticos-veterinaria. Accessed 2025\u201311\u201318."},{"key":"5474_CR5","unstructured":"Estonian Agriculture and Food Board. Mikroobivastaste ravimite ja vaktsiinide kasutusandmete aruanne aastatel 2023\u20132024. https:\/\/pta.agri.ee\/sites\/default\/files\/documents\/2025-11\/Mikroobivastaste%20ravimite%20ja%20vaktsiinide%20kasutusandmete%20aruanne%202023-2024.pdf. Accessed 2025\u201311\u201318."},{"key":"5474_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fvets.2020.00216","volume":"7","author":"A Schnepf","year":"2020","unstructured":"Schnepf A, Bienert-Zeit A, Ertugrul H, Wagels R, Werner N, Hartmann M, et al. Antimicrobial usage in horses: the use of electronic data, data curation, and first results. Front Vet Sci. 2020;7:216.","journal-title":"Front Vet Sci"},{"issue":"3","key":"5474_CR7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/evj.13988","volume":"56","author":"RE Tallon","year":"2024","unstructured":"Tallon RE, Whitt B, Bladon BM. Antibiotic usage in 14 equine practices over a 10-year period (2012-2021). Equine Vet J. 2024;56(3):544\u201351.","journal-title":"Equine Vet J"},{"issue":"9","key":"5474_CR8","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3390\/antibiotics14090953","volume":"14","author":"R Merle","year":"2025","unstructured":"Merle R, Feuer L, Frenzer K, Plenio J-L, Bethe A, Sarnino N, et al. Antibiotic use in horses: analysis of 57 German Veterinary Practices (2018\u20132023). Antibiotics. 2025;14(9):953.","journal-title":"Antibiotics"},{"issue":"3-4","key":"5474_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1751-0147-44-121","volume":"44","author":"A Albihn","year":"2003","unstructured":"Albihn A, B\u00e5verud V, Magnusson U. Uterine microbiology and antimicrobial susceptibility in isolated bacteria from mares with fertility problems. Acta Vet Scand. 2003;44(3\u20134):121\u20139.","journal-title":"Acta Vet Scand"},{"issue":"2","key":"5474_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/evj.12738","volume":"50","author":"MS Ferrer","year":"2018","unstructured":"Ferrer MS, Palomares R. Aerobic uterine isolates and antimicrobial susceptibility in mares with post-partum metritis. Equine Vet J. 2018;50(2):202\u20137.","journal-title":"Equine Vet J"},{"issue":"S2","key":"5474_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/rda.14390","volume":"58","author":"OB Pascottini","year":"2023","unstructured":"Pascottini OB, Aurich C, England G, Grahofer A. General and comparative aspects of endometritis in domestic species: a review. Reprod Domest Anim. 2023;58(S2):49\u201371.","journal-title":"Reprod Domest Anim"},{"key":"5474_CR12","unstructured":"Norwegian Medical Products Agency. Terapianbefaling: Bruk av antibakterielle midler til hest (English: Treatment guidelines: Use of antibacterial agents in horses). 2019. https:\/\/www.dmp.no\/globalassets\/documents\/veterinarmedisin\/terapianbefalinger\/terapianbefaling-antibakterielle-midler-til-hest-260619.pdf."},{"issue":"1","key":"5474_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkn444","volume":"63","author":"CG Giske","year":"2009","unstructured":"Giske CG, Sundsfjord AS, Kahlmeter G, Woodford N, Nordmann P, Paterson DL, et al. Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother. 2009;63(1):1\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"5474_CR14","unstructured":"European Medicines Agency. Categorisation of antibiotics in the European Union - Answer to the request from the European Commission for updating the scientific advice on the impact on public health and animal health of the use of antibiotics in animals. https:\/\/www.ema.europa.eu\/en\/documents\/report\/categorisation-antibiotics-european-union-answer-request-european-commission-updating-scientific-advice-impact-public-health-animal-health-use-antibiotics-animals_en.pdf. Accessed 2025\u201311\u201318."},{"key":"5474_CR15","unstructured":"WHO\u2019s List of Medically Important Antimicrobials: a risk management tool for mitigating antimicrobial resistance due to non-human use. Geneva: World Health Organization; 2024. ISBN 978\u201392\u20134\u2013008462\u20139 (print version) \/ ISBN 978\u201392\u20134\u2013008461\u20132 (electronic version). https:\/\/cdn.who.int\/media\/docs\/default-source\/gcp\/who-mia-list-2024-lv.pdf?sfvrsn=3320dd3d_2."},{"key":"5474_CR16","first-page":"1","volume":"65","author":"European Commission","year":"2022","unstructured":"European Commission. Commission implementing regulation (EU) 2022\/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans, in accordance with Regulation (EU) 2019\/6 of the European Parliament and of the Council (Text with EEA relevance). Off J Eur Union. 2022;65:1\u201382.","journal-title":"Off J Eur Union"},{"issue":"3","key":"5474_CR17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3201\/eid1103.040481","volume":"11","author":"JS Weese","year":"2005","unstructured":"Weese JS, Archambault M, Willey BM, Hearn P, Kreiswirth BN, Said-Salim B, et al. Methicillin-resistant Staphylococcus aureus in horses and horse personnel, 2000-2002. Emerg Infect Dis. 2005;11(3):430\u20135.","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"5474_CR18","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/antibiotics12091362","volume":"12","author":"H Lade","year":"2023","unstructured":"Lade H, Kim J-S. Molecular determinants of \u03b2-lactam resistance in Methicillin-Resistant Staphylococcus aureus (MRSA): an updated review. Antibiotics. 2023;12(9):1362.","journal-title":"Antibiotics"},{"key":"5474_CR19","unstructured":"NORM\/NORM-VET 2024. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Troms\u00f8 \/ \u00c5s \/ Oslo: 2025. ISSN:1502\u20132307 (print)\/1890\u20139965 (electronic). https:\/\/www.vetinst.no\/overvaking\/antibiotikaresistens-norm-vet."},{"key":"5474_CR20","first-page":"134","volume":"3","author":"K Grave","year":"2019","unstructured":"Grave K, Hopp P, J\u00f8rgensen H, Helgesen K, Tronerud O. Use of antibiotics for dogs in 2017 (In Norwegian: Bruk av antibiotika til hund i 2017 \u2013 en analyse av VetReg data). Nor Vet Tidsskr. 2019;3:134\u201340.","journal-title":"Nor Vet Tidsskr"},{"key":"5474_CR21","unstructured":"Norwegian Food Safety Authority. Opplysninger som m\u00e5 f\u00f8res p\u00e5 resepten. 2025. https:\/\/www.mattilsynet.no\/dyr\/dyrehelsepersonell\/rapportering-til-vetreg-og-koder-til-resepter\/opplysninger-som-ma-fores-pa-resepten. Accessed 2026\u201302\u201325."},{"key":"5474_CR22","unstructured":"Lovdata.no. Forskrift Om Melding Av Opplysninger Om Utleverte Og Brukte Legemidler Til Dyr. 2009. https:\/\/lovdata.no\/dokument\/SF\/forskrift\/2009-07-03-971. Accessed 2025\u201311\u201318."},{"key":"5474_CR23","unstructured":"EUR-Lex. Regulation (EU) 2019\/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products repealing Directive 2001\/82\/EC. 2019. http:\/\/data.europa.eu\/eli\/reg\/2019\/6\/oj."},{"key":"5474_CR24","unstructured":"EUR-Lex. Commission Delegated Regulation (EU) 2021\/578 of 29 January 2021 supplementing Regulation (EU) 2019\/6 of the European Parliament and of the Council with regard to requirements for the collection of data on the volume of sales and on the use of antimicrobial medicinal products in animals. 2021. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/ALL\/?uri=CELEX:32021R0578."},{"issue":"1","key":"5474_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12917-024-04460-7","volume":"21","author":"T Udhwani","year":"2025","unstructured":"Udhwani T, Dean KR, Sommerset I, Helgesen KO. Quality assessment of fish vaccine data in the Norwegian Veterinary Prescription Register (VetReg). BMC Vet Res. 2025;21(1):17.","journal-title":"BMC Vet Res"},{"issue":"1","key":"5474_CR26","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12917-025-04903-9","volume":"21","author":"T Udhwani","year":"2025","unstructured":"Udhwani T, Grave K, Hopp P, Helgesen KO. Quality assessment of antibiotic use data in the Norwegian veterinary prescription register for 2023. BMC Vet Res. 2025;21(1):510.","journal-title":"BMC Vet Res"},{"key":"5474_CR27","unstructured":"Authority NFS. Kodeverk - Landdyrsykdom (no). https:\/\/skjema.mattilsynet.no\/MtWebServices\/docs\/KODEVERK_LANDDYRSYKDOM_no.html. Accessed"},{"key":"5474_CR28","unstructured":"Lovdata.no. Forskrift om grossistvirksomhet med legemidler. 1994. https:\/\/lovdata.no\/dokument\/LTI\/forskrift\/1993-12-21-1219. Accessed 2025\u201311\u201318."},{"issue":"1","key":"5474_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00401706.1969.10490657","volume":"11","author":"FE Grubbs","year":"1969","unstructured":"Grubbs FE. Procedures for detecting outlying observations in samples. Technometrics. 1969;11(1):1\u201321.","journal-title":"Technometrics"},{"key":"5474_CR30","volume-title":"R: A language and enviroment for statistical computing","author":"R Development Core Team","year":"2024","unstructured":"R Development Core Team. R: A language and enviroment for statistical computing. 4.4.2 ed. Vienna, Austria: R Foundation for statistical computing; 2024.","edition":"4.4.2 ed"},{"key":"5474_CR31","unstructured":"National Horse Registry. https:\/\/www.nhest.no\/?cat=475258. Accessed 2025\u201312\u201302."},{"key":"5474_CR32","unstructured":"Falk M RA, Wolff C, Paulson B, Hofshagen M (editor). Dyrehelserapporten 2024 (English: Animal Health Report 2024). Norwegian Veterinary Institute Report series #21\/2025 (ISSN1890\u20133290). \u00c5s, Norway: Norwegian Veterinary Institute; 2025. https:\/\/www.vetinst.no\/rapporter-og-publikasjoner\/rapporter\/2025\/dyrehelserapporten-2024\/_\/attachment\/inline\/c0e27358-e672-4e3d-88aa-301ead53b706:231523db8f82cfc562515b8e1002a5f024ee7e39\/2025_21_Dyrehelserapporten%202024%20KOMPLETT.pdf."},{"key":"5474_CR33","unstructured":"Falk M RA, Wolff C, Heier B T, Paulson B, Hofshagen M (editor). Dyrehelserapporten 2023 (English: Animal Health Report 2023). Norwegian Veterinary Institute Report series #22\/2024 (ISSN1890\u20133290). \u00c5s, Norway: Norwegian Veterinary Institute; 2024. https:\/\/www.vetinst.no\/rapporter-og-publikasjoner\/rapporter\/2024\/dyrehelserapporten-2023\/_\/attachment\/inline\/325afdfa-d754-43eb-a953-5a27d044c2b8:1316ef96381fc96e6f3253c9733dec94f8036cb2\/DHR_2023_KOMPLETT.pdf."},{"key":"5474_CR34","volume-title":"European Sales and Use of Antimicrobials for veterinary medicine (ESUAvet). Annual surveillance report for 2024 (EMA\/CVMP\/ESUAVET\/376993\/2025)","author":"European Medicines Agency","year":"2025","unstructured":"European Medicines Agency. European Sales and Use of Antimicrobials for veterinary medicine (ESUAvet). Annual surveillance report for 2024 (EMA\/CVMP\/ESUAVET\/376993\/2025). Luxembourg: European Medicines Agency; 2025."},{"key":"5474_CR35","unstructured":"Lovdata.no. Forskrift om rekvirering og utlevering av legemidler m.m. 2022. https:\/\/lovdata.no\/dokument\/SF\/forskrift\/2022-06-02-977\/. Accessed 2025\u201311\u201328."},{"key":"5474_CR36","unstructured":"Dyrehelseportalen. https:\/\/dhp.animalia.no\/. Accessed 2026\u201301\u201306."},{"key":"5474_CR37","unstructured":"Norwegian Food Safety Authority. Sende, selge eller reise med hest fra Norge til EU\/E\u00d8S-land. https:\/\/www.mattilsynet.no\/dyr\/kjaeledyr\/hest\/hest-til-eu-eos-land. Accessed 2026\u201301\u201318."},{"key":"5474_CR38","unstructured":"Animalia - the Norwegian Meat and Poultry Research Centre. Norwegian: \u00c5rsmelding 2024 for KOORIMP og KIF. https:\/\/www.animalia.no\/globalassets\/koorimp---import---bilder-og-dokumenter\/koorimp-arsmelding-2024-web.pdf. Accessed 2026\u201301\u201318."},{"key":"5474_CR39","unstructured":"Bundesamt f\u00fcr Verbraucherschutz und Lebensmittelsicherheit (BVL) Bericht zur Resistenzmonitoringstudie 2023 (Report on the resistance monitoring study 2023). Berlin, Germany: BVL; 2025.https:\/\/www.bvl.bund.de\/SharedDocs\/Berichte\/07_Resistenzmonitoringstudie\/Bericht_Resistenzmonitoring_2023.pdf;jsessionid=5BCFFC4A6979B9C70AA1AB808FFA454E.internet942?__blob=publicationFile&v=2."},{"key":"5474_CR40","unstructured":"Felleskatalogen.no. ATC kode QJ01. 2026. https:\/\/www.felleskatalogen.no\/medisin-vet\/atc-register\/QJ01. Accessed 2026\u201302\u201326."},{"key":"5474_CR41","unstructured":"L\u00f6fling LL, Helgesen KO. Quality Evaluation of the Norwegian Veterinary Prescription Registry (VetReg) \u2013 comparing antibiotic data for 2023 and 2024. Norwegian Veterinary Institute Report series #47\/2025 (ISSN1890\u20133290). \u00c5s, Norway: Norwegian Veterinary Institute; 2025. https:\/\/www.vetinst.no\/rapporter-og-publikasjoner\/rapporter\/2025\/vetreg-comparing-antibiotic-data-for-2023-and-2024\/_\/attachment\/inline\/faa70873-1682-462e-b535-e6887cb23eca:a613d57411dea36514215c5a4ebb3c61537d0842\/2025_47_VetReg_quality_report_2024%20KOMPLETT.pdf."},{"key":"5474_CR42","unstructured":"Danish Veterinary and Food Administration. VetStat. https:\/\/vetstat.fvst.dk\/vetstat\/. Accessed 2025\u201312\u201310."}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-026-05474-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-026-05474-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-026-05474-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:09:47Z","timestamp":1781647787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12917-026-05474-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5474"],"URL":"https:\/\/doi.org\/10.1186\/s12917-026-05474-z","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to particpate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LLL\u2019s spouse is employed by MSD Norway. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"282"}}